First case of more dangerous mpox found outside Africa

Sweden's public health agency has recorded what it says is the first case of a more dangerous type of mpox outside the African continent.

The person became infected during a stay in an area of Africa where there is currently a major outbreak of mpox Clade 1, the agency said.

The news comes just hours after the World Health Organization (WHO) declared that the outbreak of mpox in parts of Africa was now a public health emergency of international concern.

At least 450 people died during an initial outbreak in the Democratic Republic of Congo and the disease has since spread to areas of Central and East Africa.

According to Olivia Wigzell, the Acting Head of the Swedish public health agency, the infected person had sought care in the Stockholm area and the fact that they were receiving treatment in Sweden did not mean there was a risk to the broader population.

Wigzell says the affected person has also been infected during a stay in an area of Africa where there is a large outbreak of mpox Clade 1.

Mpox, which was previously known as monkeypox, is transmitted through close contact, such as sex, skin-to-skin contact and talking or breathing close to another person.

It causes flu-like symptoms, skin lesions and can be fatal, with four in 100 cases leading to death.

It is most common in the tropical rainforests of West and Central Africa and there are thousands of infections every year. There are currently a number of outbreaks of mpox that are taking place simultaneously and they are partly fuelled by the newer and more serious type of Clade 1b, identified in September last year.

There are two types of Clade 1 and the Swedish case has been identified as Clade 1b.

WHO/Europe said it was actively engaging with Sweden's health authorities on "how best to manage the first confirmed case of mpox Clade 1b".

Vaccines are available, for those at greatest risk or who have been in close contact with an infected person, but many experts worry there are not enough jabs or funding to get them to the people who need them most.

Source: BBC